Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Medtrade Products Limited maintains a portfolio within the Biotechnology & Pharmaceuticals technology area, currently showing 3 pending office actions. These actions are distributed across 3 distinct examiners, indicating a diverse range of review perspectives for the company's filings. This distribution occurs across 2 distinct art units, suggesting the portfolio spans multiple specialized technical classifications within the biotechnology sector.
ARBLE, JESSICA R is the busiest examiner for this portfolio, currently managing 1 pending office action. With 3 pending office actions assigned to 3 distinct examiners, the workload is spread across multiple individuals rather than being concentrated. This parity across the portfolio reflects a balanced prosecution environment where individual examiner tendencies are likely to have a localized impact on specific applications. The presence of 3 distinct examiners across 2 distinct art units suggests that the company is navigating different examination styles simultaneously, which may require a varied approach to response strategies.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| Double-patenting + other | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ARBLE, JESSICA R | 1 | 66.3% | +25.4% |
| PALLAY, MICHAEL B | 1 | 55.8% | +34.0% |
| FISHER, VICTORIA HICKS | 1 | 40.5% | +38.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18158156 | HAEMOSTATIC MATERIAL | PALLAY, MICHAEL B | 72d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18158156 | HAEMOSTATIC MATERIAL | PALLAY, MICHAEL B | 72d overdue |
| 18886074 | WOUND DRESSING | ARBLE, JESSICA R | — |
| 15569724 | WOUND DRESSING | FISHER, VICTORIA HICKS | — |
| Art Unit | Apps |
|---|---|
| 1617 | 1 |
| 3786 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18886074 | WOUND DRESSING | ARBLE, JESSICA R | — | §102§103§112DP | Non-Final OA | — | Pending | Sep 16, 2024 |
| 18158156 | HAEMOSTATIC MATERIAL | PALLAY, MICHAEL B | 1617 | §103§112 | Final Rejection | 72d overdue | Pending | Jan 23, 2023 |
| 15569724 | WOUND DRESSING | FISHER, VICTORIA HICKS | 3786 | §103 | Final Rejection | — | Pending | Oct 26, 2017 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial